Key terms
About SMTI
Sanara MedTech, Inc.engages in the development, marketing, and distribution of biotechnology products to physicians, hospitals, and clinics. It offers CellerateRX Surgical Activated Collagen Adjuvant and HemaQuell Resorbable Bone Hemostat. The company was founded in 1982 and is headquartered in Fort Worth, TX.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest SMTI news
Apr 18
9:32am ET
Sanara MedTech Secures $55 Million Term Loan with Strategic Conditions
Apr 18
9:21am ET
Sanara MedTech announces $55M debt facility
Apr 05
9:33am ET
Sanara MedTech Welcomes Jacob Waldrop as New COO
Apr 05
9:04am ET
Sanara MedTech appoints Jake Waldrop as COO
Mar 27
7:25am ET
Sanara MedTech price target lowered to $44 from $49 at Cantor Fitzgerald
No recent press releases are available for SMTI
SMTI Financials
Key terms
Ad Feedback
SMTI Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
SMTI Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
